Video Coaching of Physical Activity in Axial Spondyloarthritis
Condition(s) studied
Investigational drug(s) / intervention(s)
Video coaching exercises: Patients will perform physical exercises following a specifical video coaching program during 6 months.
Routine exercises: Routine method by advising and encouraging patients to perform exercises according to the WHO recommendations during the first 3 months of the study. Thereafter, patients will have access to the video coaching program of physical activities during the following 3 months.
Study summary
The primary objective of the study is to demonstrate the beneficial effect of a 3 months home-based physical exercise program supervised by online videos, in addition to the usual recommendations, in comparison with usual physical activity as recommended by the WHO.
The secondary objectives of the study are :
1. to compare the following criteria between 2 groups at 3 and 6 months:
* quality of life;
* other measures of disease activity ;
* sleep quality ;
* walking ability
* muscle strength of;
* professional activity;
* cost of cares;
* evolution of weight, BMI and waist.
2. to evaluate the observance of physical activity program and its tolerance at 3 and 6 months.
Eligibility
Primary outcome measure(s)
- Proportion of patients responding to the "ASAS 20" criterion at 3 months — at 3 months
The primary outcome measure will be the proportion of patients simultaneously satisfying both criteria : * at least 20% improvement * improvement of at least 10 points on visual analog scale in the following domains: overall evaluation by the patient, visual analog scale (pain scale), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Service de rhumatologie, Hôpital Ambroise Paré | Boulogne-Billancourt | Hauts-de-Seine |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03965650 on ClinicalTrials.gov ↗ ← All trials in France